International
Europe
Trinity has been working on the key challenges facing our European clients for over 25 years. We have 45+ Trinity experts located in Europe and have completed 1,200 EU projects in the past 5 years.
Blog
Key Takeaways from the ISPOR Europe 2022 Conference
Last month, Trinity attended the ISPOR Europe 2022 conference in Vienna. The main theme of the conference was “Collaborating Across Borders: Building & Using Evidence to Enable Access”, which facilitated many interesting discussions amongst different stakeholders in life sciences, including manufacturers, regulatory leaders and health economists. Among the myriad of topics covered, digital health emerged […]
Read More
Blog
The German Financial Stabilization of Statutory Health Insurance System Act
Executive Summary: Key Policy Updates AMNOG Rebate Negotiations AMNOG* rebate negotiations will be modified to give the GKV-SV increased powers in the pricing negotiations. HIGH P&MA IMPACT: The new negotiation framework increases the threshold of added benefit required for therapies to receive a premium vs. comparator therapies, specifically by limiting the pricing of ‘No Added […]
Read More
Scientific Publications
Burden of cremophor-related paclitaxel therapy on patients with ovarian cancer: A patient focused study from the United Kingdom, Germany, and Spain.
This study aimed to characterize the burden associated with CrEL-paclitaxel treatment on patients with ovarian cancer, including clinical, safety, and quality of life implications.
Read More
Senior Partner,
Head of Strategic Advisory
Partner, Strategic Advisory
& Munich Office Lead
Partner, Value, Access & Pricing
& London Office Lead
Managing Director
Senior Partner,
Head of Advisory and Evidence, Value, Access and Pricing (EVAP)
Partner,
Value, Access & Pricing
Partner,
Value, Access & Pricing
If you have any questions, we’re here to answer them.
We look forward to helping identify solutions for you.